Cystatin C, β-2-microglobulin and β-trace protein in pre-eclampsia

References

• Lindheimer MD, Cunningham FG. Chesley's hypertensive disorders in pregnancy2nd edn, F.G. Cunningham. Appleton & Lange. 1999
   Google Scholar
• Newman MG, Robichaux AG, Stedman CM, Jaekle RK, Fontenot MT, Dotson T, et al. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol. 2003; 188(1)264–8
   PubMed Web of Science ®Google Scholar
• Lindheimer MD, Umans JG. Explaining and predicting preeclampsia. N Engl J Med. 2006; 355(10)1056–8
   PubMed Web of Science ®Google Scholar
• Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol. 1995; 22(11)781–91
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Torffvit O, Grubb A. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest. 2002; 62(2)141–7
   PubMed Web of Science ®Google Scholar
• Roberts JM. Pregnancy-related hypertension. Maternal-fetal medicine: principles and practice3d edn, RK Creasy, R Resnik. WB Saunders, Philadelphia 1994; 804–43
   Google Scholar
• Filler G, Priem F, Lepage N, Sinha P, Vollmer I, Clark H, et al. Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem. 2002; 48(5)729–36
   PubMed Web of Science ®Google Scholar
• Kristensen K, Lindström V, Schmidt C, Blirup-Jensen S, Grubb A, Wide-Swensson D, , et al. Temporal changes of the plasma levels of cystatin C, beta-trace protein, beta2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process Scand J Clin Lab Invest 2007 ( in press).
   Google Scholar
• Saudan PJ, Farrell TJ, Brown MA. Beta2-microglobulin in hypertensive pregnancies. Am J Kidney Dis. 1998; 31(2)308–12
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest. 2001; 61(7)575–80
   PubMed Web of Science ®Google Scholar
• Haddad B, Desvaux D, Livingston JC, Barranger E, Paniel BJ, Sibai BM. Failure of serum beta2-microglobulin levels as an early marker of preeclampsia. Am J Obstet Gynecol. 2000; 182(3)595–8
   PubMed Web of Science ®Google Scholar
• Ben-Haroush A, Bardin R, Erman A, Hod M, Chen R, Kaplan B, et al. Beta2-microglobulin and hypertensive complications in pregnant women at risk. Clin Nephrol. 2002; 58(6)411–6
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, et al. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. BJOG. 2003; 110(9)825–30
   PubMed Web of Science ®Google Scholar
• Gifford RW, August PA, Cunningham G, Green LA, Lindheimer MD, McNellis D, et al. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000; 183(1)S1–S22
   PubMed Web of Science ®Google Scholar
• The Declaration of Helsinki World Med J. 1982;29(6):86–8.
   PubMedGoogle Scholar
• Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994; 40(10)1921–6
   PubMed Web of Science ®Google Scholar
• Priem F, Althaus H, Birnbaum M, Sinha P, Conradt HS, Jung K. Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. Clin Chem. 1999; 45(4)567–8
   PubMed Web of Science ®Google Scholar
• Town MHGS, Hammer B, Ziegenhorn J. A sensitive colorimetric method for the enzymatic determination of uric acid. J Clin Chem Clin Biochem. 1985; 23: 591–4
   Google Scholar
• Solberg HE. The theory of reference values Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem. 1983; 21(11)749–60
   PubMedGoogle Scholar
• Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993; 39(4)561–77
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983; 148(3)839–43
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol. 2004; 104(6)1367–91
   PubMed Web of Science ®Google Scholar
• Thangaratinam S, Ismail KM, Sharp S, Coomarasamy A, Khan KS. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG. 2006; 113(4)369–78
   PubMed Web of Science ®Google Scholar
• Schuster E, Weppelmann B. Plasma urate measurements and fetal outcome in preeclampsia. Gynecol Obstet Invest. 1981; 12(3)162–7
   PubMed Web of Science ®Google Scholar
• Sagen N, Haram K, Nilsen ST. Serum urate as a predictor of fetal outcome in severe pre-eclampsia. Acta Obstet Gynecol Scand. 1984; 63(1)71–5
   PubMed Web of Science ®Google Scholar
• Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol. 1996; 174(1 Pt 1)288–91
   PubMed Web of Science ®Google Scholar